Ashtanga Vaidyam Ayurvedics Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Ashtanga Vaidyam Ayurvedics Pharmaceutical Export Portfolio Dataset — 5 Products, $145.6K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ashtanga Vaidyam Ayurvedics — Pharmaceutical Exporter Profile (2026) | 5 Products, $145.6K Trade | TransData Nexus

Ashtanga Vaidyam Ayurvedics

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $145.6K Total Trade · DGFT Verified

Ashtanga Vaidyam Ayurvedics is an Indian pharmaceutical exporter with a total trade value of $145.6K across 5 products in 1 therapeutic categories. Based on 583 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Taila ($106.5K), Arishta ($15.3K), Kwatha ($13.0K).

Ashtanga Vaidyam Ayurvedics — Export Portfolio & Destination Treemap

Ashtanga Vaidyam Ayurvedics pharmaceutical export portfolio — 5 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Ashtanga Vaidyam Ayurvedics? — Company Overview & Market Position

Ashtanga Vaidyam Ayurvedics, also known as K.S. Varier's Ashtanga Ayurvedics Private Limited, was established in 1999 and is headquartered in Trichy, Tamil Nadu, India. The company specializes in the manufacturing of Ayurvedic pharmaceutical formulations, including tablets, capsules, syrups, and injections. As a private limited entity, it is classified under the Corporate Identification Number (CIN) U24233TN1999PTC041899. The authorized capital stands at ₹2.00 crore, with a paid-up capital of ₹1.85 crore. The latest available financial data indicates that the company is active and operational. For more information, the official website is ashtangam.com.

What Does Ashtanga Vaidyam Ayurvedics Export? — Product Portfolio Analysis

Top Products by Export Value

1Taila$106.5K 2Arishta$15.3K

Product Portfolio — Top 5 by Export Value

Ashtanga Vaidyam Ayurvedics exports 5 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Taila	Ayurvedic & Herbal Products	$106.5K	326	1.4%	8
2	Arishta	Ayurvedic & Herbal Products	$15.3K	63	1.1%	10
3	Kwatha	Ayurvedic & Herbal Products	$13.0K	88	2.4%	12
4	Asava	Ayurvedic & Herbal Products	$5.8K	44	1.3%	9
5	Ghrita	Ayurvedic & Herbal Products	$5.1K	62	1.1%	3

Ashtanga Vaidyam Ayurvedics exports 5 pharmaceutical products across 1 therapeutic categories with a total export value of $145.6K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Ashtanga Vaidyam Ayurvedics — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Ashtanga Vaidyam Ayurvedics operates manufacturing facilities in Trichy, Tamil Nadu, India. The company specializes in the production of Ayurvedic pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding plant capacities and specialized manufacturing processes are not publicly disclosed. The facilities are designed to adhere to stringent quality standards, ensuring the efficacy and safety of their products.

3Key Leadership

The leadership team at Ashtanga Vaidyam Ayurvedics includes:

Soolapani Thekke Variam Varier: Managing Director, appointed on 27 July 2016.

Sasi Thirumuppath Raghavan: Whole-Time Director, appointed on 27 July 2016.

Madhavan Unnikrishnan: Additional Director, appointed on 21 May 2025.

Girish Sasi Varrier: Additional Director, appointed on 21 May 2025.

These individuals play pivotal roles in steering the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Ashtanga Vaidyam Ayurvedics Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Ashtanga Vaidyam Ayurvedics has a presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports finished pharmaceutical formulations, such as Taila, Arishta, Kwatha, Asava, and Ghrita, with a total export value of $146,000 USD across 583 shipments. These products are classified under the Ayurvedic & Herbal Products category. Specific details regarding regulatory filings, approvals, and market access status in these regions are not publicly disclosed.

2Emerging Markets

Ashtanga Vaidyam Ayurvedics has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's commitment to quality and adherence to international standards have facilitated its entry into these regions. While specific details regarding WHO prequalification and other certifications enabling access to these markets are not publicly disclosed, the company's global footprint indicates a strategic approach to market diversification.

3Geographic Strategy

The company's export portfolio is entirely concentrated in the Ayurvedic & Herbal Products category, with the top five products accounting for 100% of the export value. This indicates a high level of portfolio concentration, which may expose the company to risks associated with market fluctuations and regulatory changes in the Ayurvedic sector. Diversifying the product portfolio and exploring new therapeutic categories could mitigate such risks and enhance the company's market resilience.

Ashtanga Vaidyam Ayurvedics — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Ashtanga Vaidyam Ayurvedics' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly disclosed. The company's export data indicates a presence in the U.S. market, suggesting compliance with FDA regulations for the export of Ayurvedic pharmaceutical formulations. However, without publicly available records, a comprehensive assessment of the company's FDA status cannot be conducted.

2WHO & EU GMP

Ashtanga Vaidyam Ayurvedics' commitment to quality is evident in its adherence to international standards. While specific details regarding WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly disclosed, the company's global export activities suggest compliance with these standards. However, without publicly available records, a comprehensive assessment of the company's certifications cannot be conducted.

3CDSCO & Indian Regulatory

Ashtanga Vaidyam Ayurvedics — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Ashtanga Vaidyam Ayurvedics operates in the Ayurvedic pharmaceutical sector, competing with other manufacturers of Ayurvedic formulations. While specific market share data and a head-to-head analysis are not publicly available, the company's export data indicates a presence in various international markets, suggesting a competitive position in the global Ayurvedic pharmaceutical industry. The company's focus on quality and adherence to international standards contribute to its competitive edge.

2Key Differentiators

Ashtanga Vaidyam Ayurvedics' key differentiators include its longstanding heritage in Ayurvedic medicine, established in 1936, and its commitment to quality and innovation. The company's product portfolio, consisting of over 300 formulations, reflects its dedication to providing a diverse range of Ayurvedic solutions. Additionally, the company's focus on research and development for innovative natural therapies and its collaborations with leading firms in the field further distinguish it in the market.

3Strategic Position

Ashtanga Vaidyam Ayurvedics' current strategic direction focuses on the manufacturing and export of Ayurvedic pharmaceutical formulations. The company's emphasis on quality, research and development, and adherence to international standards positions it well in the global market. Future strategic initiatives may include diversifying the product portfolio, exploring new therapeutic categories, and expanding into additional international markets to enhance growth and mitigate risks associated with market concentration.

Buyer Due Diligence Brief — Evaluating Ashtanga Vaidyam Ayurvedics as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Ashtanga Vaidyam Ayurvedics has demonstrated a consistent track record in the export of Ayurvedic pharmaceutical formulations, with a total export value of $146,000 USD across 583 shipments. The company's reliability is indicated by its established presence in various international markets and its adherence to quality standards. However, specific details regarding export volume consistency and other reliability indicators are not publicly disclosed.

2Certifications to Verify

Importers should verify the following certifications when considering products from Ashtanga Vaidyam Ayurvedics:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure compliance with World Health Organization Good Manufacturing Practice standards.

EU GMP Certification: Verify adherence to European Union Good Manufacturing Practice standards.

Frequently Asked Questions — Ashtanga Vaidyam Ayurvedics

How many pharmaceutical products does Ashtanga Vaidyam Ayurvedics export from India?

Ashtanga Vaidyam Ayurvedics exports 5 pharmaceutical products across 1 therapeutic categories. The top exports are Taila ($106.5K), Arishta ($15.3K), Kwatha ($13.0K), Asava ($5.8K), Ghrita ($5.1K). Total export value is $145.6K.

What is Ashtanga Vaidyam Ayurvedics's total pharmaceutical export value?

Ashtanga Vaidyam Ayurvedics's total pharmaceutical export value is $145.6K, based on 583 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Ashtanga Vaidyam Ayurvedics cover?

Ashtanga Vaidyam Ayurvedics exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 5 products).

Get Full Ashtanga Vaidyam Ayurvedics Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.